Research articles (1)
Neurology Today (lww.com) How Charcot-Marie-Tooth Affects Employment Options Real-world Study Highlights Impact of CMT1A Symptoms | Charcot-Marie-Tooth News Identity-by-descent analysis […]
Continue Reading
Neurology Today (lww.com) How Charcot-Marie-Tooth Affects Employment Options Real-world Study Highlights Impact of CMT1A Symptoms | Charcot-Marie-Tooth News Identity-by-descent analysis […]
Continue Reading
Augustine Therapeutics: time to reverse nerve damage in patients undergoing chemotherapy or with Charcot-Marie-Tooth disease – BioVox
Continue ReadingNew Data from the Open-Label PLEO-CMT-FU Trial Shows SustainedBenefit with PXT3003 in Patients with Charcot-Marie-Tooth Disease Type1A After 5 Years […]
Continue ReadingDr Liliane Massade – PNP22 nanoparticles are effective in treating mouse models of CMT 1A – YouTube In this presentation, […]
Continue ReadingPress Release Pharnext Announces PXT3003 for the Treatment of CharcotMarie-Tooth Disease Type 1A has Been Granted Promising Innovative Medicine (PIM) […]
Continue ReadingLast Updated: Thursday 19th March, 2020